Get access

Emerging therapeutics in sleep

Authors

  • Clifford B. Saper MD, PhD,

    Corresponding author
    1. Department of Neurology, Program in Neuroscience, and Division of Sleep Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
    • Address correspondence to Dr Saper, Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail: csaper@bidmc.harvard.edu

    Search for more papers by this author
  • Thomas E. Scammell MD

    1. Department of Neurology, Program in Neuroscience, and Division of Sleep Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
    Search for more papers by this author

Abstract

The development of new therapeutics for sleep disorders is increasingly dependent upon understanding the basic brain circuitry that underlies sleep–wake regulation, and how it may be pharmacologically manipulated. In this review, we consider the pathophysiological basis of major sleep disorders that often are seen by neurologists, including excessive daytime sleepiness, insomnia, narcolepsy, rapid eye movement sleep behavior disorder, and restless legs syndrome, as well as circadian disorders, and we review the current and potential future therapeutic approaches. Ann Neurol 2013;74:435–440

Ancillary